Search results for "wom"

showing 10 items of 1179 documents

Exposure to Perfluoroalkyl Substances and Metabolic Outcomes in Pregnant Women: Evidence from the Spanish INMA Birth Cohorts

2017

BACKGROUND: Exposure to perfluoroalkyl substances (PFASs) may increase risk for metabolic diseases; however, epidemiologic evidence is lacking at the present time. Pregnancy is a period of enhanced tissue plasticity for the fetus and the mother and may be a critical window of PFAS exposure susceptibility. OBJECTIVE: We evaluated the associations between PFAS exposures and metabolic outcomes in pregnant women. METHODS: We analyzed 1,240 pregnant women from the Spanish INMA [Environment and Childhood Project (INfancia y Medio Ambiente)] birth cohort study (recruitment period: 2003-2008) with measured first pregnancy trimester plasma concentrations of four PFASs (in nanograms/milliliter). We u…

0301 basic medicinemedicine.medical_specialtyC-reactive protein/metabolismHealth Toxicology and Mutagenesis010501 environmental sciences01 natural sciencesCohort Studies03 medical and health sciencesEmbarassadesFluorocarbons/bloodPregnancyEnvironmental healthGlucose IntoleranceHumansmedia_common.cataloged_instanceMedicineEuropean unionAlkanesulfonic acids/bloodEnvironmental pollutants/blood0105 earth and related environmental sciencesmedia_commonFluorocarbonsbusiness.industryObstetricsResearchPregnant womenPublic Health Environmental and Occupational HealthHispanic or LatinoUniversity hospitalMetabolisme3. Good healthDiabetes GestationalC-Reactive Protein030104 developmental biologyMetabolismAlkanesulfonic AcidsCaprylates/bloodEnvironmental PollutantsFemaleMaternal exposureChristian ministryCaprylatesbusinessBirth cohortCohort study
researchProduct

Assessing the Contribution of Relative Macrophage Frequencies to Subcutaneous Adipose Tissue

2021

Background: Macrophages play an important role in regulating adipose tissue function, while their frequencies in adipose tissue vary between individuals. Adipose tissue infiltration by high frequencies of macrophages has been linked to changes in adipokine levels and low-grade inflammation, frequently associated with the progression of obesity. The objective of this project was to assess the contribution of relative macrophage frequencies to the overall subcutaneous adipose tissue gene expression using publicly available datasets.Methods: Seven publicly available microarray gene expression datasets from human subcutaneous adipose tissue biopsies (n = 519) were used together with TissueDecod…

0301 basic medicinemedicine.medical_specialtyDOWN-REGULATIONsubcutaneous adipose tissueEndocrinology Diabetes and MetabolismAdipose tissueAdipokine030209 endocrinology & metabolismInflammationBiologycell-type composition03 medical and health scienceschemistry.chemical_compound0302 clinical medicineDownregulation and upregulationINFLAMMATIONInternal medicineGene expressionlipid metabolismmedicinelow-grade inflammationpublicly available dataMacrophagecomputational deconvolutionTX341-641OXIDATIVE STRESSPHOSPHORYLATIONFatty acid synthesisGENE-EXPRESSIONNutritionOriginal ResearchINSULIN-RESISTANCENutrition and DieteticsNutrition. Foods and food supplyWOMENLipid metabolismmacrophages030104 developmental biologyEndocrinologychemistryOBESITYmedicine.symptomSTEM-CELLSFood ScienceACID-METABOLISMFrontiers in Nutrition
researchProduct

Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures

2019

Summary Guidance is provided in an international setting on the assessment and specific treatment of postmenopausal women at low, high and very high risk of fragility fractures. Introduction The International Osteoporosis Foundation and European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis published guidance for the diagnosis and management of osteoporosis in 2019. This manuscript seeks to apply this in an international setting, taking additional account of further categorisation of increased risk of fracture, which may inform choice of therapeutic approach. Methods Clinical perspective and updated literature search. Results The following areas are reviewed: …

0301 basic medicinemedicine.medical_specialtyFRAXEndocrinology Diabetes and MetabolismeducationOsteoporosisPsychological interventioninhibitors of bone resorption030209 endocrinology & metabolismRisk AssessmentAnabolic agents03 medical and health sciencesTherapeutic approach0302 clinical medicineBone DensityRisk FactorsTreatment of osteoporosisInternal medicinemedicinefracture risk assessmentHumansanabolic agentsIntensive care medicineOsteoporosis PostmenopausalAgedAnabolic agents Fracture risk assessment FRAX Inhibitors of bone resorption Treatment of osteoporosisddc:616Postmenopausal womenbusiness.industryCorrectionFracture risk assessmentInhibitors of bone resorptionMiddle Agedtreatment of osteoporosismedicine.diseaseRheumatologyIncreased riskFemalePosition Paper030101 anatomy & morphologybusinessVery high riskAlgorithmsOsteoporotic FracturesFRAXOsteoporosis International
researchProduct

Women in LOVe: Lacto-Ovo-Vegetarian Diet Rich in Omega-3 Improves Vasomotor Symptoms in Postmenopausal Women. An Exploratory Randomized Controlled Tr…

2019

Objective:In the postmenopausal period, most women suffer vasomotor symptoms (VMS). It is well-known that VMS can worsen the quality of life. Diet seems to play a relevant role in the development of VMS, but the effect of diet on VMS is mainly limited to observational studies, and analyses of nutritional supplements. The aim of this study was thus to determine the efficacy of a lactoovo- vegetarian (LOVe) diet rich in omega-3 fatty acids vs. a lacto-ovo-vegetarian diet rich in EVO (extra-virgin olive oil) in reducing VMS frequency in postmenopausal women.Methods:A two-arms (lacto-ovo-vegetarian diet with EVO vs. lacto-ovo-vegetarian diet rich in omega-3) randomized-controlled trial with a f…

0301 basic medicinemedicine.medical_specialtyTime FactorsEndocrinology Diabetes and MetabolismSweatinglaw.invention03 medical and health sciences0302 clinical medicinePrimary outcomeRandomized controlled triallawInternal medicineFatty Acids Omega-6medicineImmunology and AllergyHumans030212 general & internal medicine030109 nutrition & dieteticsPostmenopausal womenVasomotorbusiness.industryDiet VegetarianAnthropometryMiddle Agedmedicine.diseaseMenopausePostmenopauseVasomotor SystemTreatment OutcomeItalyHot FlashesObservational studyFemaleDiet menopause omega 3 lacto-ovo-vegetarian RCT Kupperman indexbusinessNutritive ValueBiomarkersOlive oilVegetariansEndocrine, metabolicimmune disorders drug targets
researchProduct

Cost-effectiveness of buffered soluble alendronate 70 mg effervescent tablet for the treatment of postmenopausal women with osteoporosis in Italy

2021

Summary The use of buffered soluble alendronate 70 mg effervescent tablet, a convenient dosing regimen for bisphosphonate therapy, seems a cost-effective strategy compared with relevant alternative treatments for postmenopausal women with osteoporosis aged 60 years and over in Italy. Introduction To assess the cost-effectiveness of buffered soluble alendronate (ALN) 70 mg effervescent tablet compared with relevant alternative treatments for postmenopausal osteoporotic women in Italy. Methods A previously validated Markov microsimulation model was adjusted to the Italian healthcare setting to estimate the lifetime costs (expressed in €2019) per quality-adjusted life-years (QALY) of buffered …

0301 basic medicinemedicine.medical_specialtyeconomic evaluationCost effectivenessCost-Benefit AnalysisEndocrinology Diabetes and Metabolismmedicine.medical_treatmentOsteoporosisUrology030209 endocrinology & metabolismAlendronate . Buffered soluble alendronate . Cost-effectiveness . Economic evaluation . Effervescent tablets . Osteoporosis . TreatmentAlendronate; Buffered soluble alendronate; Cost-effectiveness; Economic evaluation; Effervescent tablets; Osteoporosis; Treatment; Aged; Alendronate; Cost-Benefit Analysis; Female; Humans; Italy; Middle Aged; Observational Studies as Topic; Postmenopause; Quality-Adjusted Life Years; Tablets; Bone Density Conservation Agents; Osteoporosis; Osteoporosis Postmenopausal03 medical and health sciences0302 clinical medicinemedicineHumansEffervescent tabletOsteoporosis PostmenopausalAgedBone mineralPostmenopausal womenBone Density Conservation AgentstreatmentAlendronatebusiness.industrybuffered soluble alendronateMiddle AgedBisphosphonatemedicine.diseaseosteoporosisPostmenopauseObservational Studies as TopicDenosumabZoledronic acidItalyeffervescent tabletsPostmenopausalFemaleOriginal ArticleCost-effectivenessQuality-Adjusted Life Years030101 anatomy & morphologybusinessTabletsmedicine.drugOsteoporosis International
researchProduct

High intensity aquatic exercise or daily physical activity for maintaining fat mass and walking ability for postmenopausal women with knee osteoarthr…

2016

030203 arthritis & rheumatology030222 orthopedicsmedicine.medical_specialtyPostmenopausal womenbusiness.industryHigh intensityPhysical activityAquatic exerciseBiomedical EngineeringOsteoarthritismedicine.diseaseFat mass03 medical and health sciences0302 clinical medicineRheumatologyPhysical therapymedicineOrthopedics and Sports MedicinebusinessOsteoarthritis and Cartilage
researchProduct

ASSOCIATION BETWEEN LEISURE TIME PHYSICAL ACTIVITY LEVEL AND ARTICULAR CARTILAGE IN POSTMENOPAUSAL WOMEN WITH MILD KNEE OSTEOARTHRITIS: A 12-MONTH FO…

2016

030203 arthritis & rheumatologymedicine.medical_specialtyPostmenopausal womenbusiness.industryLeisure timeBiomedical EngineeringArticular cartilageOsteoarthritismedicine.diseasePhysical activity level03 medical and health sciences0302 clinical medicineRheumatologyIntervention (counseling)medicinePhysical therapyOrthopedics and Sports MedicinebusinessMonth follow up
researchProduct

Efficacy of Tailored Exercise Therapy on Physical Functioning in Patients With Knee Osteoarthritis and Comorbidity: A Randomized Controlled Trial

2017

Objective: To evaluate the efficacy on physical functioning and safety of tailored exercise therapy in patients with knee osteoarthritis (OA) and comorbidities. Methods: In a randomized controlled trial, 126 participants were included with a clinical diagnosis of knee OA and at least 1 of the following target comorbidities: coronary disease, heart failure, type 2 diabetes mellitus, chronic obstructive pulmonary disease, or obesity (body mass index ≥30 kg/m2), with severity score ≥2 on the Cumulative Illness Rating Scale. The intervention group received a 20-week, individualized, comorbidity-adapted exercise program consisting of aerobic and strength training and training of daily activities…

030203 arthritis & rheumatologymedicine.medical_specialtyWOMACRehabilitationbusiness.industryStrength trainingmedicine.medical_treatmentOsteoarthritismedicine.diseaseComorbiditylaw.invention03 medical and health sciences0302 clinical medicineRheumatologyRandomized controlled triallawmedicinePhysical therapy030212 general & internal medicineExercise physiologybusinessBody mass indexArthritis Care & Research
researchProduct

Menstrual dysfunction and body weight dissatisfaction among Finnish young athletes and non-athletes.

2020

To determine the prevalence of menstrual dysfunction (MD; i.e. oligomenorrhea or amenorrhea) and attitudes towards body weight among athletes and non‐athletes, we studied a cohort of athletes and non‐athletes, in adolescence (14–16 years) and subsequently in young adulthood (18–20 years). We further studied the differences between athletes reporting MD and eumenorrheic athletes at both time periods and identified physical and behavioural characteristicsthat might predict MD in young adulthood. Data were collected using questionnaires, accelerometers, and a pre‐participation screening. In adolescence, the athletes reported current primary amenorrhea more often than the non‐athletes (4.7% vs.…

030204 cardiovascular system & hematologyCohort Studies0302 clinical medicinenuoretSurveys and QuestionnairesAccelerometryliikuntalääketiedeContraceptive Agents FemalePrevalenceOrthopedics and Sports MedicineYoung adultpainoindeksiAmenorrhearuumiinkuvaFinlandMenstruation Disturbancesyoung athletesbiologyAge FactorsmurrosikäBody Dysmorphic DisordersMenstruationkuukautiskiertoCohortAmenorrheaFemalemedicine.symptomClinical psychologymenstrual dysfunctionAdolescentbody weight dissatisfactionPhysical Therapy Sports Therapy and RehabilitationkuukautisetBody weightamenorrhea03 medical and health sciencesYoung AdultmedicineBody Imageexercising womenHumansPrimary amenorrheaAthletesbusiness.industryBody Weight030229 sport sciencesbiology.organism_classificationOligomenorrheaAthletesbusinessEnergy MetabolismurheilijatScandinavian journal of medicinescience in sportsREFERENCES
researchProduct

Can hip resurfacing be safely revised with short-stem total hip arthroplasty? A case series of six patients.

2021

Abstract Background The usage of short stems in primary total hip arthroplasty (THA) has constantly gained popularity over the last decade, however, to date, short stems are not eligible to be used as revision implants. The aim of this study was to retrospectively evaluate the outcome of revision surgery of failed hip resurfacing arthroplasty (HRA) using short-stem THA. Methods In a single center, retrospective analysis, 6 consecutive patients who were treated with a calcar-guided short stem after failure of HRA were evaluated. The mean follow-up was 3.25 years (SD 0.45). Patient reported outcome measurements (PROMs) were recorded using the Harris hip score (HHS) and The Western Ontario and…

030222 orthopedicsmedicine.medical_specialtyWOMACbusiness.industryVisual analogue scalemedicine.medical_treatment030229 sport sciencesOsteoarthritisStress shieldingmedicine.diseaseArthroplastyHip resurfacingSurgery03 medical and health sciences0302 clinical medicineHarris Hip ScoreMedicineOrthopedics and Sports MedicinePatient-reported outcomebusinessJournal of orthopaedics
researchProduct